Novo Nordisk launches its weight-loss drug Wegovy in China after approval by local health authorities in June.

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June.

Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Should he make it through the nomination process, Kennedy plans to follow Trump’s mandate to remove “corruption” from HHS-led ...

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

A new report from AAA says newer systems prevent twice the number of collisions—and save lives. Regulators have ordered an ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

Investors can buy the stock at an incredibly modest 27 times next year's expected earnings (based on analyst estimates), ...

While Novo Nordisk’s CEO Lars Fruergaard Jørgensen has defended the high U.S. prices of the company’s blockbuster drugs, ...